Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis

Yai-Ping Hsiao,1 Hui-Ting Chen,1 Yu-Chih Liang,2 Tse-En Wang,1 Kai-Hung Huang,3 Cheng-Chih Hsu,3 Hong-Jen Liang,4 Chung-Hsiung Huang,5 Tong-Rong Jan1 1Department of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, Taipei 10617, Taiwan; 2School of Medical Laboratory Sci...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hsiao YP, Chen HT, Liang YC, Wang TE, Huang KH, Hsu CC, Liang HJ, Huang CH, Jan TR
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	experimental autoimmune encephalomyelitis honokiol nanosome neuroinflammation ultra-high pressure homogenization Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/30eb5c5173cc4b7684bf86974bc0b784
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:30eb5c5173cc4b7684bf86974bc0b784
record_format	dspace
spelling	oai:doaj.org-article:30eb5c5173cc4b7684bf86974bc0b7842021-12-02T09:52:48ZDevelopment of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis1178-2013https://doaj.org/article/30eb5c5173cc4b7684bf86974bc0b7842020-01-01T00:00:00Zhttps://www.dovepress.com/development-of-nanosome-encapsulated-honokiol-for-intravenous-therapy--peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Yai-Ping Hsiao,1 Hui-Ting Chen,1 Yu-Chih Liang,2 Tse-En Wang,1 Kai-Hung Huang,3 Cheng-Chih Hsu,3 Hong-Jen Liang,4 Chung-Hsiung Huang,5 Tong-Rong Jan1 1Department of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, Taipei 10617, Taiwan; 2School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 10617, Taiwan; 3Department of Chemistry, National Taiwan University, Taipei 10617, Taiwan; 4Department of Food Science, Yuanpei University, Hsinchu 30015, Taiwan; 5Department of Food Science, National Taiwan Ocean University, Keelung 20224, TaiwanCorrespondence: Tong-Rong JanDepartment and Graduate Institute of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, No.1, Sec. 4, Roosevelt Road, Taipei 10617, Taiwan, ROCTel +886-2-33661287Fax +886-2-23661475Email tonyjan@ntu.edu.twChung-Hsiung HuangDepartment of Food Science, National Taiwan Ocean University, No.2, Beining Road, Keelung 20224, TaiwanTel +886-2-24622192#5115Email huangch@mail.ntou.edu.twBackground: Honokiol has been reported to possess anti-inflammatory and neuroprotective activities. However, the poor aqueous solubility of honokiol limits its clinical application for systemic administration.Purpose: This study aims to develop a novel formulation of nanosome-encapsulated honokiol (NHNK) for intravenous therapy against mouse experimental autoimmune encephalomyelitis (EAE) that mimics human multiple sclerosis.Methods: Nanosomes and NHNK were prepared by using an ultra-high pressure homogenization (UHPH) method. Mice were treated with NHNK or empty nanosomes during the peak phase of EAE symptoms. Symptoms of EAE were monitored and samples of the spinal cord were obtained for histopathological examinations.Results: The stock of NHNK containing honokiol in the nanosome formulation, which showed the structure of single phospholipid bilayer membranes, was well formulated with the particle size of 48.0 ± 0.1 nm and the encapsulation efficiency 58.1 ± 4.2%. Intravenous administration of NHNK ameliorated the severity of EAE accompanied by a significant reduction of demyelination and inflammation in the spinal cord. Furthermore, NHNK decreased the number of IL-6+, Iba-1+TNF +, Iba-1+IL-12 p40+, and CD3+IFN-γ+ cells infiltrating the spinal cord.Conclusion: The UHPH method simplified the preparation of NHNK with uniformly distributed nanosize and high encapsulation efficiency. Intravenous administration of NHNK ameliorated the severity of EAE by suppressing the infiltration of activated microglia and Th1 cells into the spinal cord. Collectively, these results suggest that the formulation of NHNK is a prospective therapeutic approach for inflammatory CNS diseases, such as multiple sclerosis.Keywords: experimental autoimmune encephalomyelitis, honokiol, nanosome, neuroinflammation, ultra-high pressure homogenizationHsiao YPChen HTLiang YCWang TEHuang KHHsu CCLiang HJHuang CHJan TRDove Medical Pressarticleexperimental autoimmune encephalomyelitishonokiolnanosomeneuroinflammationultra-high pressure homogenizationMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 17-29 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	experimental autoimmune encephalomyelitis honokiol nanosome neuroinflammation ultra-high pressure homogenization Medicine (General) R5-920
spellingShingle	experimental autoimmune encephalomyelitis honokiol nanosome neuroinflammation ultra-high pressure homogenization Medicine (General) R5-920 Hsiao YP Chen HT Liang YC Wang TE Huang KH Hsu CC Liang HJ Huang CH Jan TR Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis
description	Yai-Ping Hsiao,1 Hui-Ting Chen,1 Yu-Chih Liang,2 Tse-En Wang,1 Kai-Hung Huang,3 Cheng-Chih Hsu,3 Hong-Jen Liang,4 Chung-Hsiung Huang,5 Tong-Rong Jan1 1Department of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, Taipei 10617, Taiwan; 2School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 10617, Taiwan; 3Department of Chemistry, National Taiwan University, Taipei 10617, Taiwan; 4Department of Food Science, Yuanpei University, Hsinchu 30015, Taiwan; 5Department of Food Science, National Taiwan Ocean University, Keelung 20224, TaiwanCorrespondence: Tong-Rong JanDepartment and Graduate Institute of Veterinary Medicine, School of Veterinary Medicine, National Taiwan University, No.1, Sec. 4, Roosevelt Road, Taipei 10617, Taiwan, ROCTel +886-2-33661287Fax +886-2-23661475Email tonyjan@ntu.edu.twChung-Hsiung HuangDepartment of Food Science, National Taiwan Ocean University, No.2, Beining Road, Keelung 20224, TaiwanTel +886-2-24622192#5115Email huangch@mail.ntou.edu.twBackground: Honokiol has been reported to possess anti-inflammatory and neuroprotective activities. However, the poor aqueous solubility of honokiol limits its clinical application for systemic administration.Purpose: This study aims to develop a novel formulation of nanosome-encapsulated honokiol (NHNK) for intravenous therapy against mouse experimental autoimmune encephalomyelitis (EAE) that mimics human multiple sclerosis.Methods: Nanosomes and NHNK were prepared by using an ultra-high pressure homogenization (UHPH) method. Mice were treated with NHNK or empty nanosomes during the peak phase of EAE symptoms. Symptoms of EAE were monitored and samples of the spinal cord were obtained for histopathological examinations.Results: The stock of NHNK containing honokiol in the nanosome formulation, which showed the structure of single phospholipid bilayer membranes, was well formulated with the particle size of 48.0 ± 0.1 nm and the encapsulation efficiency 58.1 ± 4.2%. Intravenous administration of NHNK ameliorated the severity of EAE accompanied by a significant reduction of demyelination and inflammation in the spinal cord. Furthermore, NHNK decreased the number of IL-6+, Iba-1+TNF +, Iba-1+IL-12 p40+, and CD3+IFN-γ+ cells infiltrating the spinal cord.Conclusion: The UHPH method simplified the preparation of NHNK with uniformly distributed nanosize and high encapsulation efficiency. Intravenous administration of NHNK ameliorated the severity of EAE by suppressing the infiltration of activated microglia and Th1 cells into the spinal cord. Collectively, these results suggest that the formulation of NHNK is a prospective therapeutic approach for inflammatory CNS diseases, such as multiple sclerosis.Keywords: experimental autoimmune encephalomyelitis, honokiol, nanosome, neuroinflammation, ultra-high pressure homogenization
format	article
author	Hsiao YP Chen HT Liang YC Wang TE Huang KH Hsu CC Liang HJ Huang CH Jan TR
author_facet	Hsiao YP Chen HT Liang YC Wang TE Huang KH Hsu CC Liang HJ Huang CH Jan TR
author_sort	Hsiao YP
title	Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis
title_short	Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis
title_full	Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis
title_fullStr	Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis
title_full_unstemmed	Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis
title_sort	development of nanosome-encapsulated honokiol for intravenous therapy against experimental autoimmune encephalomyelitis
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/30eb5c5173cc4b7684bf86974bc0b784
work_keys_str_mv	AT hsiaoyp developmentofnanosomeencapsulatedhonokiolforintravenoustherapyagainstexperimentalautoimmuneencephalomyelitis AT chenht developmentofnanosomeencapsulatedhonokiolforintravenoustherapyagainstexperimentalautoimmuneencephalomyelitis AT liangyc developmentofnanosomeencapsulatedhonokiolforintravenoustherapyagainstexperimentalautoimmuneencephalomyelitis AT wangte developmentofnanosomeencapsulatedhonokiolforintravenoustherapyagainstexperimentalautoimmuneencephalomyelitis AT huangkh developmentofnanosomeencapsulatedhonokiolforintravenoustherapyagainstexperimentalautoimmuneencephalomyelitis AT hsucc developmentofnanosomeencapsulatedhonokiolforintravenoustherapyagainstexperimentalautoimmuneencephalomyelitis AT lianghj developmentofnanosomeencapsulatedhonokiolforintravenoustherapyagainstexperimentalautoimmuneencephalomyelitis AT huangch developmentofnanosomeencapsulatedhonokiolforintravenoustherapyagainstexperimentalautoimmuneencephalomyelitis AT jantr developmentofnanosomeencapsulatedhonokiolforintravenoustherapyagainstexperimentalautoimmuneencephalomyelitis
_version_	1718397936649371648

Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis

Ejemplares similares